Neuraxis Inc (NRXS) Directors and Executive Officers

Officers & Directors

Timothy R. Henrichs
Chief Financial Officer (Principal)

Brian Carrico
Chief Executive Officer and Director

Kristin Ferge
Director

Beth Keyser
Director

Christopher Robin Brown
Director

Bradley Mitch Watkins
Director,

Neuraxis Inc currently has 24 employees.

News about Neuraxis Inc Key Personnel

NeurAxis Inc.: Bridging Challenges and Triumphs in Neuromodulation Therapy

In the rapidly evolving healthcare sector, NeurAxis Inc. (NYSE American: NRXS) is a notable player, focusing on the commercialization of neuromodulation therapies aimed at alleviating chronic ailments in both children and adults. A recent letter from CEO Brian Carrico to shareholders provided insights into the company’s trajectory, including achievements in 2024 and a vision for the forthcoming year. However, the company is navigating a landscape marked by substantial financial challenges.Financial Performance and Losses:During the 12 months leading up to the third quarter of 2024, NeurAxis recorded a cumulative net loss of $14 million, which translates to a staggering negative return on assets (ROA) of -1...

NeurAxis Expands Access to Percutaneous Electrical Nerve Field Stimulation with New Coverage Agreements in Pennsylvania and North Dakota

NeurAxis Expands Access to Percutaneous Electrical Nerve Field Stimulation with New Coverage Agreements in Pennsylvania and North DakotaCARMEL, Ind. — NeurAxis, Inc. (NYSE American: NRXS), a pioneering medical technology company focused on neuromodulation therapies for chronic and debilitating conditions, has made significant strides in expanding access to its innovative treatment, Percutaneous Electrical Nerve Field Stimulation (PENFS). Effective October 1, 2024, Capital Blue Cross will provide medical policy coverage for PENFS to its members in a 21-county region across Central Pennsylvania and the Lehigh Valley. This addition marks a crucial milestone for NeurAxis, as it broadens the availability of thi...